Welcome to our dedicated page for Perrigo Co Plc SEC filings (Ticker: PRGO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Perrigo Company plc filings document a consumer health issuer organized under Irish law, with disclosures covering operating results, non-GAAP measures, segment reporting, capital structure, governance, and material corporate events. Recent 8-K filings report quarterly earnings from continuing operations, the company's transition to product-category segments, and the completed sale of its Dermacosmetics branded business.
The filing record also covers Perrigo's ordinary shares, senior notes, revolving credit facility, and term loan arrangements, including amendments to credit agreements. Proxy and annual meeting materials document board matters, shareholder voting results, executive compensation, and the shareholder-approved 2026 Long-Term Incentive Plan.
Perrigo Company plc director Geoffrey M. Parker reported routine equity compensation activity involving ordinary shares and restricted stock units. He exercised 976 restricted stock units into ordinary shares at $10.99 per share, and 469 ordinary shares were withheld to cover tax obligations. He also received a new grant of 844 restricted stock units, each representing a contingent right to one ordinary share, vesting on June 12, 2027. In addition to his direct holdings, ordinary shares are held indirectly through a Roth IRA and a revocable trust.
Manzone Albert reported acquisition or exercise transactions in this Form 4 filing.
Perrigo Company plc interim President and CEO Albert Manzone received a grant of 1,069 Restricted Stock Units (RSUs) on Ordinary Shares. Each RSU represents a contingent right to receive one ordinary share, vesting on June 12, 2027. Following these transactions, he holds 16,353 Ordinary Shares directly.
Perrigo Company plc director Bradley A. Alford reported compensation-related share movements. On June 12 2026, he exercised 976 Restricted Stock Units into Ordinary Shares at $10.99 per share, with 469 shares withheld to cover tax obligations. He also received a new grant of 2,559 Restricted Stock Units, each representing a contingent right to one Ordinary Share that vests on June 12 2027. Following these transactions, he directly holds 45,465.148 Ordinary Shares.
Perrigo Company plc former CEO and director Patrick Lockwood-Taylor reported compensation-related share movements, not open-market trades. On June 5, 2026, 25,230 Restricted Stock Units were exercised into ordinary shares, while 12,906 ordinary shares were disposed of at $10.83 per share to cover tax obligations. Following these transactions, he directly held 136,076 ordinary shares and 50,458 Restricted Stock Units, indicating this was an exercise-and-tax-withholding event rather than a net share purchase or sale.
Perrigo Company plc announced a leadership change as Patrick Lockwood-Taylor resigned immediately as President, CEO and board member after the board determined certain personal conduct was not consistent with the company’s Code of Conduct and core values. The company stated the conduct did not involve its business, strategy, operations, financial reporting or results.
The board appointed director Albert A. Manzone as Interim President and CEO and began a comprehensive search for a permanent successor. Perrigo reaffirmed its full-year 2026 outlook, including All In net sales growth of (5.5)% to (1.5)%, All In adjusted EPS of $2.00 to $2.30, Core net sales growth of (3.0)% to +1.0% and Core adjusted EPS of $2.25 to $2.55.
PERRIGO Co plc executive Roberto Khoury reported compensation-related share activity. On June 5, 2026, he exercised restricted stock units that converted into 17,902 ordinary shares, a non-cash acquisition recorded at $10.8300 per share. In connected transactions, 9,346 ordinary shares were disposed of to cover tax obligations through share withholding rather than open-market sales. These moves reflect routine equity compensation vesting and do not represent discretionary buying or selling of Perrigo stock.
Perrigo Company plc executive Robert Willis reported routine equity compensation activity. On June 5, 2026, he exercised 3,441 Restricted Stock Units, converting them into the same number of ordinary shares at a stated price of $0.00 per unit. To cover tax obligations, 1,797 ordinary shares were disposed of at $10.83 per share in a tax-withholding transaction, rather than an open-market sale. After these transactions, he continues to hold more than 50,000 ordinary shares directly, indicating this filing reflects compensation-related movements rather than discretionary buying or selling.
Perrigo Company plc EVP and CSO Abigail Lennox reported equity compensation activity involving ordinary shares and restricted stock units. She exercised 3,823 restricted stock units into ordinary shares at a reference price of $10.83 per share, and 1,996 shares were disposed of to cover tax obligations. Following the tax-withholding disposition, she directly holds 4,607 ordinary shares. Footnotes note that each restricted stock unit represents a right to receive one ordinary share and that certain units vest in three equal annual installments beginning 6 June 2026. These are compensation-related transactions rather than open‑market purchases or sales.
Perrigo Company plc EVP & Chief Financial Officer Eduardo Guarita Bezerra reported routine equity compensation activity. On 5 June 2026, he exercised 9,175 Restricted Stock Units, receiving the same number of ordinary shares at an accounting value of $10.83 per share. To cover related tax obligations, 2,235 ordinary shares were disposed of as a tax-withholding transaction rather than an open-market sale. Following these transactions, he directly holds 86,935 ordinary shares and 18,348 Restricted Stock Units, indicating a net increase in his equity stake.
PERRIGO Co plc EVP & CBDO David Ball exercised 2,867 Restricted Stock Units into ordinary shares on June 5, 2026. As part of the same event, 1,037 ordinary shares were disposed of to cover tax obligations through a tax-withholding arrangement, a routine compensation-related transaction rather than an open-market trade.